Your browser doesn't support javascript.
loading
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).
Barosi, G; Tefferi, A; Besses, C; Birgegard, G; Cervantes, F; Finazzi, G; Gisslinger, H; Griesshammer, M; Harrison, C; Hehlmann, R; Hermouet, S; Kiladjian, J-J; Kröger, N; Mesa, R; Mc Mullin, M F; Pardanani, A; Passamonti, F; Samuelsson, J; Vannucchi, A M; Reiter, A; Silver, R T; Verstovsek, S; Tognoni, G; Barbui, T.
Afiliación
  • Barosi G; Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  • Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Besses C; Department of Haematology, Hospital del Mar-IMIM, Barcelona, Spain.
  • Birgegard G; Department of Haematology, Uppsala University Hospital, Uppsala, Sweden.
  • Cervantes F; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Finazzi G; Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Gisslinger H; Department of Hematology, Medical University of Vienna, Vienna, Austria.
  • Griesshammer M; Academic Department of Hematology and Oncology, Johannes Wesling Teaching Hospital, Minden, Germany.
  • Harrison C; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Hehlmann R; III Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Hermouet S; 1] Inserm UMR 892, Institut de Recherche en Santé, Université de Nantes, Nantes, France [2] Chair of MPN&MPNr-EuroNet, Institut de Recherche en Santé, Université de Nantes, Nantes, France.
  • Kiladjian JJ; Centre d'Investigations Cliniques-CIC 9504, Assistance Publique -Hôpitaux de Paris, Hôpital Saint-Louis; Université Paris 7, Paris, France.
  • Kröger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Mesa R; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Mc Mullin MF; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
  • Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Passamonti F; Division of Hematology, Ospedale di Circolo di Varese, Varese, Italy.
  • Samuelsson J; Department of Medicine Stockholm South Hospital, Karolinska Institute, Stockholm, Sweden.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Reiter A; III Medizinische Universitätsklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Silver RT; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Verstovsek S; Department of Leukemia, University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
  • Tognoni G; Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.
  • Barbui T; Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Leukemia ; 29(1): 20-6, 2015 Jan.
Article en En | MEDLINE | ID: mdl-25151955
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Fusión bcr-abl / Determinación de Punto Final / Consenso / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Fusión bcr-abl / Determinación de Punto Final / Consenso / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido